PAR 5.77% 24.5¢ paradigm biopharmaceuticals limited..

2b or NOT to be, page-10

  1. 118 Posts.
    lightbulb Created with Sketch. 10
    Yes- Lots of prior art in horse and dog on top of human studies starting in the 80s (I think) in treating osteoarthritis. There is also a generic PPS approved in EEC for dog use which claims it is identical chemical to Cartrophen. DYOR
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.015(5.77%)
Mkt cap ! $85.70M
Open High Low Value Volume
26.0¢ 26.0¢ 24.5¢ $265.4K 1.050M

Buyers (Bids)

No. Vol. Price($)
8 130186 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 11571 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.